Terms: = Bone cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
1886 results:
1. [Aprospective study of detection and clinical significance of bone marrow tumor cells in small cell lung cancer].
Wang Y; Lu BH; Gao Y; Liu YX; Hu MM; Che NY; Lin HF; Li HX; Zhang HM; Zhang TM
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):419-427. PubMed ID: 38742355
[No Abstract] [Full Text] [Related]
2. A bicentric retrospective study of the correlation of EAU bcr risk groups with
Poterszman N; Merlin C; Margail C; Ouvrard E; Imperiale A; Somme F
Sci Rep; 2024 May; 14(1):10908. PubMed ID: 38740809
[TBL] [Abstract] [Full Text] [Related]
3. Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers.
Georgievski A; Bellaye PS; Tournier B; Choubley H; Pais de Barros JP; Herbst M; Béduneau A; Callier P; Collin B; Végran F; Ballerini P; Garrido C; Quéré R
Cell Death Dis; 2024 May; 15(5):328. PubMed ID: 38734740
[TBL] [Abstract] [Full Text] [Related]
4. Intracranial residual lesions following early intensification in a patient with T-cell acute lymphoblastic leukemia: a case report.
Nagamatsu Y; Isoda T; Inaji M; Oyama J; Niizato D; Tomomasa D; Mitsuiki N; Yamashita M; Kamiya T; Imai K; Kanegane H; Morio T; Takagi M
BMC Pediatr; 2024 May; 24(1):304. PubMed ID: 38704558
[TBL] [Abstract] [Full Text] [Related]
5. A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID.
Cesana D; Cicalese MP; Calabria A; Merli P; Caruso R; Volpin M; Rudilosso L; Migliavacca M; Barzaghi F; Fossati C; Gazzo F; Pizzi S; Ciolfi A; Bruselles A; Tucci F; Spinozzi G; Pais G; Benedicenti F; Barcella M; Merelli I; Gallina P; Giannelli S; Dionisio F; Scala S; Casiraghi M; Strocchio L; Vinti L; Pacillo L; Draghi E; Cesana M; Riccardo S; Colantuono C; Six E; Cavazzana M; Carlucci F; Schmidt M; Cancrini C; Ciceri F; Vago L; Cacchiarelli D; Gentner B; Naldini L; Tartaglia M; Montini E; Locatelli F; Aiuti A
Nat Commun; 2024 Apr; 15(1):3662. PubMed ID: 38688902
[TBL] [Abstract] [Full Text] [Related]
6. Discovery of a Meisoindigo-Derived PROTAC as the ATM Degrader: Revolutionizing Colorectal cancer Therapy via Synthetic Lethality with ATR Inhibitors.
Liu TT; Wang Q; Zhou Y; Ye B; Liu T; Yan L; Fan J; Xu J; Zhou Y; Xia Z; Deng X
J Med Chem; 2024 May; 67(9):7620-7634. PubMed ID: 38634707
[TBL] [Abstract] [Full Text] [Related]
7. The CNS microenvironment promotes leukemia cell survival by disrupting tumor suppression and cell cycle regulation in pediatric T-cell acute lymphoblastic leukemia.
Enlund S; Sinha I; Neofytou C; Amor AR; Papadakis K; Nilsson A; Jiang Q; Hermanson O; Holm F
Exp Cell Res; 2024 Apr; 437(2):114015. PubMed ID: 38561062
[TBL] [Abstract] [Full Text] [Related]
8. Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry.
Brioli A; Lomaia E; Fabisch C; Sacha T; Klamova H; Morozova E; Golos A; Ernst P; Olsson-Stromberg U; Zackova D; Nicolini FE; Bao H; Castagnetti F; Patkowska E; Mayer J; Hirschbühl K; Podgornik H; Paczkowska E; Parry A; Ernst T; Voskanyan A; Szczepanek E; Saussele S; Franke GN; Kiani A; Faber E; Krause S; Casado LF; Lewandowski K; Eder M; Anhut P; Gil J; Südhoff T; Hebart H; Heibl S; Pfirrmann M; Hochhaus A; Lauseker M
Leukemia; 2024 May; 38(5):1072-1080. PubMed ID: 38548962
[TBL] [Abstract] [Full Text] [Related]
9. Clinical Insights into Structure, Regulation, and Targeting of ABL Kinases in Human Leukemia.
Wu A; Liu X; Fruhstorfer C; Jiang X
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542279
[TBL] [Abstract] [Full Text] [Related]
10. Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms.
Mouhssine S; Maher N; Matti BF; Alwan AF; Gaidano G
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542207
[TBL] [Abstract] [Full Text] [Related]
11. Acute Lymphoblastic Leukemia With Near-haploid Karyotype and Philadelphia Chromosome.
Panagopoulos I; Andersen K; Wik HS; Tandsæther MR
Anticancer Res; 2024 Apr; 44(4):1389-1397. PubMed ID: 38537997
[TBL] [Abstract] [Full Text] [Related]
12. Chemotherapy-initiated cysteine-rich protein 61 decreases acute B-lymphoblastic leukemia chemosensitivity.
Shi P; Lin Z; Song Y; Li Z; Zeng M; Luo L; Cao Y; Zhu X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):159. PubMed ID: 38530432
[TBL] [Abstract] [Full Text] [Related]
13. Dynamic evolution of bone marrow adipocyte in B cell acute lymphoblastic leukemia: insights from diagnosis to post-chemotherapy.
Jia X; Liao N; Yao Y; Guo X; Chen K; Shi P
Cancer Biol Ther; 2024 Dec; 25(1):2323765. PubMed ID: 38465622
[TBL] [Abstract] [Full Text] [Related]
14. Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia.
Guo S; Mohan GS; Wang B; Li T; Daver N; Zhao Y; Reville PK; Hao D; Abbas HA
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38418394
[TBL] [Abstract] [Full Text] [Related]
15. Flow cytometric detection of leukemic blasts in Libyan pediatric patients with acute lymphoblastic leukemia.
Elbnnani AS; Elbasir M; Altabal S; Lamami Y; Ebrahim F; Oshah HM; Alagnef R; Elzagheid A; Abulayha AM
Libyan J Med; 2024 Dec; 19(1):2319895. PubMed ID: 38394044
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy of physical exercise intervention on children with acute lymphoblastic leukemia during treatment and rehabilitation: a systematic review and meta-analysis.
Liu H; Yin J; Wang K; Liu S; Yang Y; Song Z; Dong C; Zhang T; Luo J
Support Care Cancer; 2024 Feb; 32(3):177. PubMed ID: 38381189
[TBL] [Abstract] [Full Text] [Related]
17. The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in cml Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the treatment Plan.
Malagola M; Iurlo A; Bucelli C; Abruzzese E; Bonifacio M; Stagno F; Binotto G; D'Adda M; Lunghi M; Crugnola M; Ferrari ML; Lunghi F; Castagnetti F; Rosti G; Lemoli RM; Sancetta R; Coppi MR; Corsetti MT; De Gobbi M; Romano A; Tiribelli M; Russo Rossi A; Russo S; Defina M; Farina M; Bernardi S; Butturini G; Pellizzeri S; Roccaro AM; Russo D
Clin Lymphoma Myeloma Leuk; 2024 May; 24(5):323-331. PubMed ID: 38369436
[TBL] [Abstract] [Full Text] [Related]
18. Thymic-Epithelial-Cell-Dependent Microenvironment Influences Proliferation and Apoptosis of Leukemic Cells.
Patel SK; Zhdanovskaya N; Sergio I; Cardinale A; Rosichini M; Varricchio C; Pace E; Capalbo C; Locatelli F; Macone A; Velardi E; Palermo R; Felli MP
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338689
[TBL] [Abstract] [Full Text] [Related]
19. Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape.
Fontana D; Zambrotta GPM; Scannella A; Piazza R; Gambacorti-Passerini C
Ann Hematol; 2024 May; 103(5):1561-1568. PubMed ID: 38321229
[TBL] [Abstract] [Full Text] [Related]
20. Management of ALL in adults: 2024 ELN recommendations from a European expert panel.
Gökbuget N; Boissel N; Chiaretti S; Dombret H; Doubek M; Fielding A; Foà R; Giebel S; Hoelzer D; Hunault M; Marks DI; Martinelli G; Ottmann O; Rijneveld A; Rousselot P; Ribera J; Bassan R
Blood; 2024 May; 143(19):1903-1930. PubMed ID: 38306595
[TBL] [Abstract] [Full Text] [Related]
[Next]
